Carl Morrison
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Nephrology top 2%
- Parathyroid Disorders and Treatments
Papers in
- Oncology 45
- Cancer Immunotherapy and Biomarkers 22
- CAR-T cell therapy research 7
-
- Ubiquitin and proteasome pathways 7
- Epigenetics and DNA Methylation 6
- Co-authors
- Wendy L. Frankel (8 shared papers)David E. Cohn (8 shared papers)Saul Suster (5 shared papers)Cynthia M. Magro (9 shared papers)Scott D. Jewell (3 shared papers)W. Marsh (2 shared papers)Nicole Kelbick (3 shared papers)Jose A. Plaza (2 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Cancer Research (7 papers)American Journal of Clinical Pathology (7 papers)Oncotarget (6 papers)Oncogene (4 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Carl Morrison
127 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 121
- Oncology 1.4k
- Nephrology 305
- Cancer Research 554
- Dermatology 246
- Pathology and Forensic Medicine 451
Countries citing papers authored by Carl Morrison
This map shows the geographic impact of Carl Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Morrison more than expected).
Fields of papers citing papers by Carl Morrison
This network shows the impact of papers produced by Carl Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Morrison. The network helps show where Carl Morrison may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl Morrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 349 | |
| 2 | 2006 | 203 | |
| 3 | 2004 | 193 | |
| 4 | 2012 | 168 | |
| 5 | 2008 | 165 | |
| 6 | 2016 | 155 | |
| 7 | 2007 | 139 | |
| 8 | 2003 | 122 | |
| 9 | 2002 | 116 | |
| 10 | 2013 | 112 | |
| 11 | 2013 | 110 | |
| 12 | 2021 | 110 | |
| 13 | 2006 | 103 | |
| 14 | 2004 | 98 | |
| 15 | 2005 | 91 | |
| 16 | 2007 | 88 | |
| 17 | 2004 | 84 | |
| 18 | 2011 | 82 | |
| 19 | 2012 | 79 | |
| 20 | 2017 | 59 |
About Carl Morrison
Carl Morrison is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cancer Research, having authored 130 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Cancer Genomics and Diagnostics (11 papers), Immunotherapy and Immune Responses (10 papers), Ferroptosis and cancer prognosis (8 papers), Ubiquitin and proteasome pathways (7 papers), CAR-T cell therapy research (7 papers), Epigenetics and DNA Methylation (6 papers) and Cutaneous lymphoproliferative disorders research (6 papers). The work is most often cited by research in Oncology (1.4k citations), Nephrology (305 citations), Cancer Research (554 citations), Dermatology (246 citations) and Pathology and Forensic Medicine (451 citations). Carl Morrison has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Wendy L. Frankel, David E. Cohn, Saul Suster, Cynthia M. Magro, Scott D. Jewell, W. Marsh, Nicole Kelbick, Jose A. Plaza, Jeffrey M. Fowler and Gerard J. Nuovo. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, American Journal of Clinical Pathology, Oncotarget and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.